A highly effective hormonal balancing cream used to relieve the symptoms of PMS and menopause. This product contains the whole root and does not contain estrogen or progesterone. This product comes highly recommended. Look here

A recent study in Japan indicates that B12 treatment helps in the growth and division of certain immune system cells.11 These cells function to prevent the immune system from over-reacting to allergens such as animals, mold, dust, safe pro hormone and pollen. they are called suppressor cells or cd8+ pro lymphocytes. they “put the brakes on the immune system”. this medicationtm is a 21-day treatment of b12 lozenges sucked on twice daily. this medicationtm may help patients with hay fever by providing hormone the patient’s suppressor cells with the sustained and elevated blood b12 level they need to grow and divide. it appears that by helping the immune system to become what it is genetically capable of becoming, this safe medicationtm pro turns hormone at least some safe allergic people into non-allergic or moderately-allergic people.

studies indicate that ingested oral cyanocobalamin tablets are ineffective in the treatment pro of allergic disease, perhaps because once ingested, they are directly metabolized in the liver. when b12 is delivered via injection hormone or lozenge it passes throughout the bloodstream before arriving at the liver. it is during this first pass in its native form that it is believed to exert its therapeutic effect. clinical research: "the world health organization (who) recognizes allergic rhinitis (hay fever), sinusitis, asthma,...conjunctivitis, safe urticaria, eczema, dermatitis (contact and atopic)...allergic pro and hormone and migraine headache...as diseases in which ige-mediated allergy may be involved."1 safe in 1988, pro asthma and allergic rhinitis subjects hormone were treated with b12. total ige, specific ige and pulmonary lung functions were taken at days 45, 150 and 180 from baseline. eight of the 9 subjects had reduced ige. 2 in 1989 open label studies at two sites in riverside county, safe ca in 1989. sixteen of the 17 subjects had lowered ige levels from day 0 to day 30.3

patients gave blood serum samples prior to the treatment in 1992 and one year pro later in 1993. they were immunoassayed for specific ige antibodies using a chemi-luminescent technique. statistician bradley rosebrook ran t-tests comparing average baseline ige levels hormone to one-year. for the seasonal allergens reported, the active group (n=34) had on average a greater reduction in ige than the placebo group (n=33).7 safe and pro on august 14, 1996 representatives of broncorp, inc. met with the division director, dr. john jenkins, and 14 other fda officials of the pulmonary division at a prenda meeting. dr. mansfield made a presentation on the 1995 study data (n=165) from hormone oregon, washington and idaho. he noted that together the data failed to show statistical superiority of vitamin b12 on the primary endpoint. he noted that in washington and idaho, during the later part of the study, there was a drop in the pollen counts and marked improvements in symptoms in both the vitamin b12 and placebo safe groups. (this made a therapeutic benefit of the b12 treatment pro difficult to demonstrate.) but that the pollen counts in oregon remained higher throughout hormone and safe the study and that the data from oregon pro showed a significant hormone difference between the active and placebo groups.8